Story
GSK to Close German Vaccine Plant by 2027, 641 Jobs at Risk
Pharmaceutical giant GSK announced on Friday that it will close its vaccine manufacturing facility in Dresden, Germany, by the summer of 2027. The decision places 641 positions at risk, according to the German trade union Industriegewerkschaft Bergbau, Chemie, Energie (IGBCE).
Details of the Closure
Workers at the Dresden site, which currently produces traditional egg-based flu vaccines and hepatitis vaccines, were informed of the plan on Thursday. The closure is part of a strategic shift for the company as it moves away from older manufacturing technologies.
The IGBCE and the plant's works council have both rejected the plans and stated they will oppose the closure. The union warned the move would eliminate highly skilled industrial jobs from the Saxony region and reduce critical pharmaceutical manufacturing capacity in Germany.
AdPivot to mRNA Technology
The plant's closure coincides with GSK's progress in developing next-generation vaccines. The company is reportedly planning to move an mRNA-based seasonal influenza vaccine candidate into late-stage trials this month.
This strategic pivot is supported by promising clinical data. Mid-stage trial results indicated that the new mRNA vaccine generated stronger immune responses than currently approved standard- and high-dose flu shots for both younger and older adults, according to the source.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.
Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.
Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.
DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.